Connection
Theresa Medina to Protein Kinase Inhibitors
This is a "connection" page, showing publications Theresa Medina has written about Protein Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.153 |
|
|
|
-
Vieito M, Cabanas EG, Mehmi I, Gaudy-Marqueste C, O'Neil BH, Medina TM, Body AL, Arance A, Kummar S, Najjar YG, Bedard PL, Rankin A, Chu C, McKenna C, Hume S, Kopp LM, Lee J. Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy. JCO Precis Oncol. 2026 Oct; 10(10):e2501187.
Score: 0.153